The Food and Drug Administration has approved a first of its kind, once-yearly shot designed to protect dogs from fleas and ...

Bravecto Quantum is the first FDA-approved drug that treats and prevents flea and tick infestations on dogs for a duration of ...

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...

A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...

Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., ...

The FDA has approved a long-acting drug to protect dogs against fleas and ticks. The drug, Bravecto Quantum, is given by injection and must be prescribed by a licensed veterinarian.

Rahway, New Jersey Saturday, July 12, 2025, 09:00 Hrs [IST] ...

Bravecto Plus Topical for Cats is an 8-week topical liquid that is used to treat fleas, ticks, heartworms, roundworms, and hookworms. In addition to fluralaner, Bravecto Plus contains moxidectin.

Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said Thursday it expects its Bravecto ...

BRAVECTO QUANTUM exemplifies Merck Animal Health’s commitment to groundbreaking science and has been recognized as a winner of the 2024 Edison Awards and the 2024 S&P Global Awards for Best New ...